A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

For men with a localized recurrence following prostate cancer radiotherapy, salvage treatment with either focal therapy or surgery may offer comparable long-term cancer control, but focal therapy ...

Supreme leader of Iran who maintained theocratic rule at home and an anti-western axis of resistance in the Middle East ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry.

Good morning, everybody. My name is Kyahn Williamson, SVP of Investor Relations and Corporate Communications at Telix. And we're very pleased to welcome you today to our investor call and webcast to ...

Dr. Jacob Triplet, at IU Health Ball Memorial Hospital in Muncie, recently began using the Stryker Mako SmartRobotics device ...

AbCellera Biologics Inc. (NASDAQ: ABCL) Q4 2025 Earnings Call Transcript February 24, 2026 AbCellera Biologics Inc. beats earnings expectations. Reported EPS is $-0.02995, expectations were $-0.18.

In A Nutshell Researchers have launched a free, publicly accessible 3D atlas of real human organs that lets anyone zoom from whole-organ views down to near-cellular detail in a web browser. The scans ...

The post Markets Rebound as AMD Surges on Meta Deal: Market Analysis for February 24th, 2026 appeared first on Stock Target Advisor.

A view of Immigration and Customs Enforcement’s California City Detention Facility last July. (Patrick T. Fallon/AFP via Getty Images) Fernando Viera Reyes needed a biopsy for possible prostate cancer ...

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...

Researchers and clinicians from six leading medical centers and academic institutions—including the University of California San Diego—have collaborated to develop a new artificial intelligence model ...